cln-081
cullinan oncology,otsuka
['nsclc', 'cln-081 ', 'sclc']
#asco2022 updates:
at the ongoing #asco, presented findings from their phase i/iia study of cln-081 in #nsclc patients with egfr exon 20 insertion mutations demonstrating the therapeutic potential. for more insights, visit: 
#DelveInsight is a premier Business Consulting and Market Research firm, focused exclusively on the healthcare industry